Bispecific anti-VEGF/anti-ANG-2 antibodies

Details for Australian Patent Application No. 2009301431 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Baehner, Monika; Brinkmann, Ulrich; Georges, Guy; Griep, Remko Albert; Imhof-Jung, Sabine; Kavlie, Anita; Kettenberger, Hubert; Klein, Christian; Regula, Joerg Thomas; Schefer, Wolfgang; Schanzer, Juergen Michael; Scheuer, Werner; Seeber, Stefan; Thomas, Markus

Agent Davies Collison Cave

Pub. Number AU-A-2009301431

PCT Pub. Number WO2010/040508

Priority 08021834.0 16.12.08 EP; 08017607.6 08.10.08 EP

Filing date 7 October 2009

Wipo publication date 15 April 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/040508 Priority application(s): WO2010/040508

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301439-Method and system for producing biodiesel

2009301427-Motion and orientation simulator